FTC says pharma no to "Pharma Bro"
Regulators claim the former drug executive, who served four years in prison for fraud, is violating lifetime industry ban.
Watch CBS News
Regulators claim the former drug executive, who served four years in prison for fraud, is violating lifetime industry ban.
Federal health officials are warning people in newly-hard hit COVID areas to consider masking up in indoor public places. About a-third of the U.S. population lives in areas considered at higher risk - mostly in the Northeast and Midwest. “Pharma Bro” Martin Shkreli has been released from prison early. And “The Greatest Show on Earth” plans a comeback next year – but without animal performers. Ringling Brothers went dark in 2017.
Former pharmaceutical exec, who was sentenced to a seven-year term in 2018, will face either home confinement or a halfway house.
The so-called "Pharma Bro" is banned for life from participating in the pharmaceutical industry.
Proceeds for the sale will go towards Shkreli's court-ordered fines and payments.
Martin Shkreli was sentenced to seven years in prison Friday for cheating investors. But it was his role as outspoken pharmaceutical CEO that caused him to gain notoriety and put the spotlight on drug prices in the U.S. CBS News correspondent Anna Werner explains.
Martin Shkreli, the pharmaceutical executive convicted of defrauding investors in his hedge funds, has been sentenced to seven years in prison. CBS News Radio's Steve Dorsey tells CBSN he became an unlikely pen pal to the "Pharma Bro" behind bars.
Despite being accused of similar crimes, Theranos founder and CEO Elizabeth Holmes and so-called "pharma-bro" Martin Shkreli received very different punishments. So why the discrepancy? CBS News spoke to attorney and former federal prosecutor Emily Compagno about the cases.
Martin Shkreli, the drug company executive nicknamed "Pharma Bro," is being sentenced today for defrauding investors. CBS News Radio's Steve Dorsey joins CBSN with the story of how he became Shkreli's prision pen pal.
Former hedge fund manager and pharmaceutical CEO Martin Shkreli faces up to 20 years in prison for his conviction on security fraud and conspiracy. Shkreli became the poster boy for greed on Wall Street after raising the price of a life-saving drug 5,000 percent. Tony Dokoupil reports.
Martin Shkreli's jury has been chosen in his securities fraud trial. His reputation slowed the jury selection process with as many as 200 potential jurors dismissed. Some of the dismissed jurors said they couldn't be impartial knowing his "pharma bro" reputation.
Pharmaceutical exec Martin Shkreli's trial on charges of securities and wire fraud is getting underway. Jury selection is proving to be difficult, as more than 120 jurors have already been dismissed, most citing their dislike of Shkreli. CBS News justice reporter Paula Reid joins CBSN with more on the case.
Japanese airbag maker Takata files for bankruptcy; "Pharma bro" Martin Shkreli in court for fraud trial. These headlines and more from CBS MoneyWatch
The maker of EpiPen, a potentially life-saving medical device for severe allergic reactions, is now under Congressional scrutiny over how its cost has risen nearly 500 percent since 2009. But one prominent and controversial figure, former pharma CEO Martin Shkreli who has no connections to the EpiPen product, is defending the increase. Vinita Nair reports.
In a conversation with CBS News' Vinita Nair, controversial former CEO of Turing Pharmaceuticals defends drug-maker Mylan for its skyrocketing cost of the device that delivers a life-saving injection for people with severe allergies. Shkreli has no connection with the EpiPen product. He also claims he is "innocent" of his own, unrelated federal securities fraud charges.
Donald Trump is re-tooling his controversial immigration policy, which included a vow to deport 11 million undocumented immigrants; Mississippi firefighter Patrick Hardison's life changed in 2001 when the roof of a burning house collapsed on him
Several members of Congress are demanding to know why the price of EpiPens has skyrocketed by 500 percent. The devices deliver a life-saving injection for people with severe allergies. Vinita Nair spoke with a former pharmaceutical exec who faced similar criticism last year.
The cost of EpiPens are on the rise. Founder and former CEO of Turing Pharmaceuticals, Martin Shkreli, joins CBSN with to discuss why he believes the price hike is justified and why he raised the price of Daraprim by 5000%.
You thought you hated him before. Wait until you see this.
Hillary Clinton and Bernie Sanders argue over progressivism, "Pharma Bro" Martin Shkreli appears before Congress but refuses to testify and more are among today's CBSNews.com trending stories.
Martin Shkreli, the former head of a pharmaceutical company that jacked up prices on an AIDS drug, appeared before Congress Thursday. But he didn't have much to say. Scott Pelley has more.
Ex-pharma CEO Martin Shkreli hosted a live video chat and took questions from the public after pleading the fifth before Congress on questions unrelated to his federal charge. CBSN's Vladimir Duthiers attempts to ask Shkreli question but the embattled drug entrepreneur refuses to take media questions.
Ex-Pharma CEO Martin Shkreli was set to be grilled by members of Congress on questions unrelated to his federal indictment. CBS News justice reporter Paula Reid joins CBSN to discuss why the ex-CEO kept pleading the fifth.
Martin Shkreli, former CEO of Turing Pharmaceuticals, testified on Capitol Hill after hiking drug prices by more than 5,000 percent. Watch how lawmakers react to him invoking the Fifth Amendment.
Infamous pharma ex-CEO Martin Shkreli is known for hiking of drug prices. However, he wasn't the first. Why is it such a shock now? Financial Times senior business correspondent Michael Crow joins CBSN to discuss.